Latka logo
RevBio logo

RevBiorevenue

Lowell, MassachusettsFounded 2014CEO Daniel McKeon

RevBio, Inc., is a clinical stage medical device company developing and commercializing TETRANITE®, a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial.

revbio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$10M
Sep 2025EST
Employees
32
Sep 2025

RevBio revenue

RevBio has not published its revenue. Growjo puts it at about $10M a year (September 2025).

$0
$2.5M
$5M
$7.5M
$10M
$0
–
$10M
20142015–242025
ReportedEstimateFounded 2014 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$10MESTGrowjo estimate

RevBio CEO & employees

Daniel McKeon is CEO of RevBio. RevBio has 32 employees (September 2025, LinkedIn).

0
10
20
30
32
2025
ReportedOne figure per year; a reported figure wins over an estimate

RevBio FAQ

What is RevBio's revenue?

Growjo estimates RevBio's revenue at about $10M a year (September 2025). The company hasn't published its own figure.

How many employees does RevBio have?

RevBio has 32 employees as of September 2025, according to LinkedIn.

Who is the CEO of RevBio?

Daniel McKeon is the CEO of RevBio.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun RevBio? Join the podcast